NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

1.265 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -30.15-39.754-93.063-51.7770.4080.066-0.105
Depreciation & Amortization 0.0050.0040.0020.002000
Deferred Income Tax -2.6550-1.8135.7170.0700
Stock Based Compensation 0.3873.6287.7850.730.00100
Change In Working Capital 5.1640.699-4.8983.4530.0050.55-0.001
Accounts Receivables 000.831-0.831000
Inventory 0000000
Accounts Payables 2.655-1.611-0.0191.1830.0710.4650.086
Other Working Capital 2.5092.31-5.713.101-0.0670.084-0.087
Other Non Cash Items 5.592-4.33254.28439.61-1.277-1.554-0.115
Operating Cash Flow -21.657-39.755-37.703-2.265-0.793-0.473-0.136
Investing Activities:
Investments In Property Plant And Equipment -0.003-0.01-0.007-0.002-000
Acquisitions Net 0000000
Purchases Of Investments -0.003-0.01-0.0070-0.993-0.69-69
Sales Maturities Of Investments 000041.240.0420
Other Investing Activites 0.0030.010.00726.1760-0.648-69
Investing Cash Flow -0.003-0.01-0.007-0.00240.247-0.648-69
Financing Activities:
Debt Repayment -3.092-0.518-1.276-0.62-1.262-0.690
Common Stock Issued 9.29322.70236.9832.5790-0.00869.585
Common Stock Repurchased 0000-40.727070.025
Dividends Paid 0000000
Other Financing Activities 5.0310.0327.7491.290.0060.683-0.44
Financing Cash Flow 6.20132.21463.4563.249-39.4650.68369.585
Other Information:
Effect Of Forex Changes On Cash 00000.01200
Net Change In Cash -15.459-7.55125.7460.982-0.011-0.4380.449
Cash At End Of Period 4.59520.05427.6051.85900.0110.449